Aclaris Therapeutics, Inc. (ACRS) vs 908 Devices Inc. (MASS)
A side-by-side comparison of Aclaris Therapeutics, Inc. and 908 Devices Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACRS
Aclaris Therapeutics, Inc.
$3.74HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
MASS
908 Devices Inc.
$12.44HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
Total return — ACRS vs MASS
growth of $100 · dividends reinvested · last 6yACRS -22.6% (-4.2%/yr)MASS -73.9% (-20.0%/yr)ACRS compounded faster over this window
ACRS MASS
ACRS vs MASS: by the numbers
- •ACRS is the larger company ($522M vs $511M market cap).
- •Both run net losses; MASS's is the smaller (-56.68% vs -921.50% net margin).
- •MASS grew revenue faster over the past five years (18.92% vs 4.39% CAGR).
Metrics side by side
Valuation
| Metric | ACRS | MASS |
|---|---|---|
| P/S ratio | 63.47 | 8.39 |
| P/B ratio | 4.19 | 4.03 |
| FCF yield | N/A | 0.09% |
Profitability
| Metric | ACRS | MASS |
|---|---|---|
| Gross margin | 73.28% | 49.79% |
| Operating margin | -975.91% | -46.01% |
| Net margin | -921.50% | -56.68% |
| ROE | -60.79% | -27.20% |
| ROIC | -56.99% | -18.90% |
Growth (annualized)
| Metric | ACRS | MASS |
|---|---|---|
| Revenue CAGR (5Y) | 4.39% | 18.92% |
| Total return CAGR (5Y) | -24.23% | -17.66% |
Frequently asked
- Which has grown faster, ACRS or MASS?
- Over the past five years, MASS grew revenue faster — ACRS at a 4.39% CAGR versus MASS at 18.92%.
- How have ACRS and MASS total returns compared?
- Over the past 5 years, ACRS delivered -24.23% and MASS delivered -17.66% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Aclaris Therapeutics ROE908 Devices ROEAclaris Therapeutics operating margin908 Devices operating marginAclaris Therapeutics revenue growth908 Devices revenue growthAclaris Therapeutics free cash flow908 Devices free cash flow
Aclaris Therapeutics & 908 Devices appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.